Recruiting
Phase 1
Phase 2

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

Sponsor:

National Cancer Institute (NCI)

Code:

NCT03745326

Conditions

Gastrointestinal Cancer

Pancreatic Cancer

Gastric Cancer

Colon Cancer

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Fludarabine

Aldesleukin

anti-KRAS G12D mTCR PBL

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information